Home
Conditions
Intraocular Lymphoma

Clinical trial condition

Intraocular Lymphoma

Explore clinical trials studying Intraocular Lymphoma. Study availability and eligibility vary by location and protocol.

121 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Intraocular Lymphoma trial results

Completed

Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies

NCT01658319

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +85 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

NCT01959477

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +202 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

NCT00608361

Conditions: Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, +144 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Los Angeles County-USC Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View all 23 locations

View Trial Details

Completed

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

NCT00720135

Conditions: Anaplastic Large Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +35 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma

NCT00045500

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +40 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

Frederick Cancer Research and Development Center Frederick, Maryland, United States

View Trial Details

Completed

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

NCT00003993

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: National Institute on Aging - Baltimore Baltimore, Maryland, United States

View Trial Details

Completed

Flavopiridol in Treating Patients With Refractory Cancer

NCT00019344

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +52 more
Locations: Medicine Branch Bethesda, Maryland, United States

View Trial Details

Completed

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

NCT00049400

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +41 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

University of California Davis Cancer Center Sacramento, California, United States

Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States

View all 23 locations

View Trial Details

Completed

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

NCT00416923

Conditions: Blood Protein Disorders, Brain and Central Nervous System Tumors, Burkitt Lymphoma, +46 more
Locations: Not specified

View Trial Details

Completed

A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma

NCT00221325

Conditions: Central Nervous System Lymphoma, Eye Neoplasms, Hemic and Lymphatic Diseases, +9 more
Locations: University of California, San Francisco San Francisco, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Intraocular Lymphoma

Intraocular Lymphoma trial results

Related conditions